Stay Updated with the Latest in AGC Management

Dear Dr. Renukaprasad A R, Advanced gastric cancer (AGC) is a leading cause of cancer-related deaths worldwide. Several treatment modalities have been investigated, but only a few exhibit clinically meaningful results. Ramucirumab is used as monotherapy and in combination with paclitaxel for AGC in patients with disease progression after chemotherapy. In case you missed our earlier session on the therapeutic potential of Ramucirumab in AGC patients, grab this opportunity to be part of the next session today, from 9:30 PM IST onwards. Looking forward to your active participation in this informative discussion! Highlights: Opening remarks - Dr. Abdullah Alsharm, KSA ESMO guideline updates for treatment of AGC - Prof. Stefano Cascinu, Italy Post-IO 2L mGC case presentation - Dr. Akhil Kapoor, India Nutrition assessment and support for gastric cancer management - Ms. Lucy Eldridge, UK Panel Discussion - All Speakers Join Now Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*